Laurel Wealth Advisors LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Laurel Wealth Advisors LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$2,450
-29.5%
2,5000.0%0.00%0.0%
Q2 2023$3,475
-12.6%
2,5000.0%0.00%0.0%
Q1 2023$3,975
-74.5%
2,5000.0%0.00%
-75.0%
Q4 2022$15,575
-8.4%
2,5000.0%0.00%0.0%
Q3 2022$17,000
+6.2%
2,5000.0%0.00%0.0%
Q2 2022$16,000
+33.3%
2,5000.0%0.00%
+33.3%
Q1 2022$12,000
-7.7%
2,5000.0%0.00%0.0%
Q4 2021$13,000
-56.7%
2,5000.0%0.00%
-57.1%
Q3 2021$30,000
-43.4%
2,5000.0%0.01%
-36.4%
Q2 2021$53,000
-24.3%
2,5000.0%0.01%
-35.3%
Q1 2021$70,000
+7.7%
2,5000.0%0.02%0.0%
Q4 2020$65,000
-36.3%
2,500
-8.8%
0.02%
-43.3%
Q3 2020$102,000
+750.0%
2,740
+1041.7%
0.03%
+650.0%
Q2 2020$12,000
+50.0%
2400.0%0.00%
+33.3%
Q1 2020$8,000
-42.9%
2400.0%0.00%
-25.0%
Q4 2019$14,000
+55.6%
2400.0%0.00%
+33.3%
Q3 2019$9,000
-18.2%
2400.0%0.00%
-25.0%
Q2 2019$11,000
+10.0%
2400.0%0.00%0.0%
Q1 2019$10,000
-9.1%
2400.0%0.00%0.0%
Q4 2018$11,0002400.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders